Abstract:Yan Chen, 1 Dansheng Le, 1 Jiaxi Xu, 2 Piaopiao Jin, 3 Yuhan Zhang, 4 Zhengluan Liao 1 1 Center for Rehabilitation Medicine, Department of Psychiatry, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Psychiatry, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China; 3 Department of Psychiatry, Yiwu Central Hospital, Jin Hu, Zhejiang, People's Republic of China; 4 The Second Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China Correspondence: Zhengluan Liao, Center for Rehabilitation Medicine, Department of Psychiatry, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou, Zhejiang, People's Republic of China, Tel/Fax +86-571-87312143, Email Purpose: There are some challenges to diagnosis in the context of similar diagnostic criteria for late-life depression (LLD) and adult depression due to cognitive impairment and other clinical manifestations. The association between gut microbiota and inflammation remains unclear in LLD. We analyzed gut microbiota characteristics and serum inflammatory cytokines in individuals with LLD to explore the combined role of these two factors in potential biomarkers of LLD. Methods: This was an observational cross-sectional study. Fecal samples and peripheral blood from 29 patients and 33 sex- and age-matched healthy controls (HCs) were collected to detect gut microbiota and 12 inflammatory factors. We analyzed differences in diversity and composition of gut microbiota and evaluated relations among gut microbiota, inflammatory factors, and neuropsychological scales. We extracted potential biomarkers using receiver-operating characteristic curve analysis to predict LLD utilizing the combination of the microbiota and inflammatory cytokines. Results: Elevated systemic inflammatory cytokine levels and gut microbiota dysbiosis were found in LLD patients. Relative abundance of Verrucomicrobia at the phylum level and Megamonas, Citrobacter , and Akkermansia at the genus level among LLD patients was lower than HCs. Abundance of Coprococcus, Lachnobacterium , Oscillospira , and Sutterella was higher in LLD patients. Notably, IL6, IFNγ, Verrucomicrobia, and Akkermansia levels were correlated with depression severity. Our study identified IL6, Akkermansia , and Sutterella as predictors of LLD, and their combination achieved an area under the curve of 0.962 in distinguishing LLD patients from HCs. Conclusion: This research offers evidence of changes within gut microbiota and systemic inflammation in LLD. These findings possibly help elucidate functions of gut microbiota and systemic inflammation in LLD development and offer fresh ideas on biomarkers for clinical practise in the context of LLD. Keywords: late-life depression, gut microbiota, inflammation, inflammatory cytokines Late-life depression (LLD) is defined as a depressive disorder that occurs during old age (>60 years) 1 and includes both the first onset of depression during old age and depression that occurs prior and continues into or recurs during old age. This study focuses specifically on primary depressive disorders with first onset occurring at an older age (>60 years). With the increase in life expectancy worldwide, the prevalence of LLD has increased significantly, and approximately 4% of the world's elderly are diagnosed with LLD. 2 Although the diagnostic criteria for symptomatology of LLD and adult depression are similar, unlike depression occurring in younger adults, LLD is characterized by prominent physical symptoms, while emotional symptoms are inconspicuous and cognitive impairment more severe. 3,4 Moreover, research 4 suggests that LLD may be a precursor of dementia. Above all, it is suggested that LLD may have different pathological mechanisms from adult depression. As a result, the low rates of treatment and treatment success present a great burden to patients and society. However, the current strategy for diagnosing LLD is mainly based on mental assessment, which is subjective to some extent and subject to misdiagnosis. Therefore, there is an urgent need for a clearer understanding of the pathogenesis of LLD and a better objective biomarker for LLD. Pertinently, the microbiome–gut–brain axis has been widely studied lately and is considered a critical factor involved in the pathogenesis of neuropsychiatric diseases that involves bidirectional regulation -Abstract Truncated-

Interaction of the gut microbiota and brain functional connectivity in late-life depression

Differences in gut microbiota correlate with symptoms and regional brain volumes in patients with late-life depression

Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression

Gut Microbiota Dysbiosis and Inflammation Dysfunction in Late-Life Depression: An Observational Cross-Sectional Analysis

Altered gut bacterial-fungal interkingdom networks in children and adolescents with depression

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder

The gut microbiome from middle-aged women with depression modulates depressive-like behaviors and plasma fatty acid metabolism in female middle-aged mice

Fecal Microbiota in Pediatric Depression and Its Relation to Bowel Habits.

Variations in Gut Microbiota and Fecal Metabolic Phenotype Associated with Depression by 16S Rrna Gene Sequencing and LC/MS-based Metabolomics.

Possible Association of Firmicutes in the Gut Microbiota of Patients with Major Depressive Disorder.

A mediation analysis of the role of total free fatty acids on pertinence of gut microbiota composition and cognitive function in late life depression

Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naïve patients with major depressive disorder

Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice

Gut microbiome predicts cognitive function and depressive symptoms in late life

Gut proinflammatory bacteria is associated with abnormal functional connectivity of hippocampus in unmedicated patients with major depressive disorder

48. THE POTENTIAL MICROBIOTA BIOMARKER AND FUNCTIONAL CHARACTERISTICS BETWEEN PATIENTS WITH MAJOR DEPRESSIVE DISORDER, BIPOLAR DISORDER, AND HEALTHY CONTROLS

Gut Microbiota Alterations and Their Functional Differences in Depression According to Enterotypes in Asian Individuals

Deciphering the Gut Microbiome's Influence on Depression: A Community-Level Constraint-Based Metabolic modelling Approach

Depression-associated gut microbes, metabolites and clinical trials

Gut Microbiota Dysbiosis in Depressed Women: the Association of Symptom Severity and Microbiota Function.

Integrative Analysis of Long Non-coding RNAs, Messenger RNAs, and MicroRNAs Indicates the Neurodevelopmental Dysfunction in the Hippocampus of Gut Microbiota-Dysbiosis Mice